Arthritis Clinical Trials in San Antonio
View 29 new treatments for Arthritis in San Antonio, TX. Every day, Power helps hundreds of Arthritis patients connect with leading medical research.Baricitinib vs TNF Inhibitors for Rheumatoid Arthritis
Eli Lilly Clinic, San Antonio + 3 more
This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous thromboembolic events (VTEs) when given to participants with rheumatoid arthritis.Show More
No Placebo Trial
Baricitinib for Rheumatoid Arthritis
Eli Lilly Clinic, Pleasanton + 2 more
This trial compares the safety of two treatments for rheumatoid arthritis, focusing on the risk of blood clots. One treatment is baricitinib, an oral medication used for moderate to severe cases.Show More
No Placebo Trial
TG-C for Knee Osteoarthritis
Kolon TissueGene Clinic, San Antonio + 2 more
This trial tests TG-C, an injection into the knee, for people with moderate to severe knee osteoarthritis. It aims to see if TG-C can reduce pain and improve knee function by potentially altering the disease. The study will monitor patients for safety and effectiveness over time. TG-C has been previously studied for its potential to improve knee joint function and reduce pain in osteoarthritis patients.Show More
Tildrakizumab for Psoriatic Arthritis
Sun Clinic, San Antonio + 1 more
This trial is testing tildrakizumab, a medication that reduces inflammation, in patients with active Psoriatic Arthritis who haven't tried certain other treatments. It works by blocking a protein to help manage symptoms. Tildrakizumab is approved for treating moderate to severe plaque psoriasis.Show More
Tildrakizumab SC Injection for Psoriatic Arthritis
Sun Clinic, San Antonio + 2 more
An open label phase 3 study
No Placebo Trial
Secukinumab for Polymyalgia Rheumatica
Novartis Clinic, San Antonio + 2 more
The purpose of this extension study is to assess the safety and tolerability of secukinumab when administered long-term in patients with polymyalgia rheumatica.
No Placebo Trial
RTX-GRT7039 Injections for Knee Osteoarthritis
Grünenthal Clinic, San Antonio + 1 more
This trial uses knee injections called RTX-GRT7039 for patients with knee osteoarthritis who still have pain despite usual treatments. The injections aim to reduce knee pain, possibly by affecting pain pathways or inflammation.Show More
No Placebo Trial
Retatrutide for Obesity
Eli Lilly Clinic, San Antonio + 1 more
This trial is testing a weekly medication called retatrutide. It aims to help people who are overweight or obese and have knee osteoarthritis. The study will last over a year to see if the medication is safe and effective.Show More
Tc 99m Tilmanocept Imaging for Rheumatoid Arthritis
Navidea Biopharmaceuticals Clinic, San Antonio + 1 more
This study will confirm the ability of Tc 99m tilmanocept imaging to predict clinical response in individuals with RA who are beginning anti-TNFα therapy.
No Placebo Trial
Long-Term Safety of Filgotinib for Rheumatoid Arthritis
Galapagos NV Clinic, San Antonio + 1 more
This trial aims to check the ongoing safety and tolerability of filgotinib, a medication that helps reduce inflammation and pain. The study focuses on people with rheumatoid arthritis who have already used filgotinib in a previous study. Filgotinib works by blocking enzymes that cause inflammation, helping to reduce swelling and pain. Filgotinib has been approved for the treatment of rheumatoid arthritis in adults who respond inadequately to other treatments in Europe and Japan.Show More
Frequently Asked Questions
How much do arthritis clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range. Further, most trials will cover the costs of an Uber to-and-from the clinic. Factors that can affect compensation include the phase of the trial, the length of the trial, the frequency of visits, and the specific condition being studied.
Do I need to be insured to participate in a medical study?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on Cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
How do arthritis clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll typical be sorted into one of the treatment groups, and will receive your study drug. For some trials, there is a chance you'll receive a placebo. Across arthritis trials in San Antonio, 42% of clinical trials have a placebo. Typically you'll be required to check-in with the clinic every month or two. The average trial length in this city for arthritis patients is 6 Months.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in getting approval for a specific condition. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. Phase 2 trials are those where the drug has some data showing safety in humans, but where effectiveness has typically only been shown in animals and non-human experiments. Phase 1 trials are the trials where we don't have safety data in humans. As a general rule, phase 3 trials are more promising than phase 2, and phase 2 trials are more promising than phase 1.
Where in San Antonio is research being conducted for arthritis?
Clinical trials for arthritis in San Antonio are primarily conducted in the northwest area, with notable activity at Clinical Trials of Texas, Inc. Approximately 13 trials are ongoing as of 2024.
What promising new drugs are being tested?
In San Antonio, arthritis research is focusing on treatments like Janus Kinase (JAK) Inhibitors and Monoclonal Antibodies. Notable drugs being studied include Baricitinib, Tildrakizumab, and TNF Inhibitors.